A cutting-edge cell and gene therapy company’s clinical trial was facing a delay due to additional FDA requirements for its newer technology. The company hired Catalyst to contextualize the regulatory environment, help progress its trial and prevent regulatory hurdles for its pipeline.
Sign up for periodic updates on regulatory policy and events we are attending
